Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: QYResearch | PRODUCT CODE: 1121147

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1121147

Global Lysosomal Storage Disease Treatment Market Insights, Forecast to 2028

PUBLISHED:
PAGES: 102 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

Description

Table of Contents

List of Tables

This research report focuses on the Lysosomal Storage Disease Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Enzyme Replacement Therapy
    • 1.2.3 Stem Cell Transplantation
    • 1.2.4 Substrate Reduction Therapy
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Stem Transplant Centers
    • 1.3.5 Research Organizations
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Lysosomal Storage Disease Treatment Market Perspective (2017-2028)
  • 2.2 Lysosomal Storage Disease Treatment Growth Trends by Region
    • 2.2.1 Lysosomal Storage Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Lysosomal Storage Disease Treatment Historic Market Size by Region (2017-2022)
    • 2.2.3 Lysosomal Storage Disease Treatment Forecasted Market Size by Region (2023-2028)
  • 2.3 Lysosomal Storage Disease Treatment Market Dynamics
    • 2.3.1 Lysosomal Storage Disease Treatment Industry Trends
    • 2.3.2 Lysosomal Storage Disease Treatment Market Drivers
    • 2.3.3 Lysosomal Storage Disease Treatment Market Challenges
    • 2.3.4 Lysosomal Storage Disease Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue
    • 3.1.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue (2017-2022)
    • 3.1.2 Global Lysosomal Storage Disease Treatment Revenue Market Share by Players (2017-2022)
  • 3.2 Global Lysosomal Storage Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Lysosomal Storage Disease Treatment Revenue
  • 3.4 Global Lysosomal Storage Disease Treatment Market Concentration Ratio
    • 3.4.1 Global Lysosomal Storage Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Disease Treatment Revenue in 2021
  • 3.5 Lysosomal Storage Disease Treatment Key Players Head office and Area Served
  • 3.6 Key Players Lysosomal Storage Disease Treatment Product Solution and Service
  • 3.7 Date of Enter into Lysosomal Storage Disease Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Lysosomal Storage Disease Treatment Breakdown Data by Type

  • 4.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Type (2017-2022)
  • 4.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Type (2023-2028)

5 Lysosomal Storage Disease Treatment Breakdown Data by Application

  • 5.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Application (2017-2022)
  • 5.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 6.2 North America Lysosomal Storage Disease Treatment Market Size by Type
    • 6.2.1 North America Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 6.2.2 North America Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 6.2.3 North America Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 6.3 North America Lysosomal Storage Disease Treatment Market Size by Application
    • 6.3.1 North America Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 6.3.2 North America Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 6.3.3 North America Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 6.4 North America Lysosomal Storage Disease Treatment Market Size by Country
    • 6.4.1 North America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    • 6.4.2 North America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 7.2 Europe Lysosomal Storage Disease Treatment Market Size by Type
    • 7.2.1 Europe Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 7.2.2 Europe Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 7.2.3 Europe Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 7.3 Europe Lysosomal Storage Disease Treatment Market Size by Application
    • 7.3.1 Europe Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 7.3.2 Europe Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 7.3.3 Europe Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 7.4 Europe Lysosomal Storage Disease Treatment Market Size by Country
    • 7.4.1 Europe Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    • 7.4.2 Europe Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 8.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 9.2 Latin America Lysosomal Storage Disease Treatment Market Size by Type
    • 9.2.1 Latin America Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 9.2.2 Latin America Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 9.2.3 Latin America Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 9.3 Latin America Lysosomal Storage Disease Treatment Market Size by Application
    • 9.3.1 Latin America Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 9.3.2 Latin America Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 9.3.3 Latin America Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 9.4 Latin America Lysosomal Storage Disease Treatment Market Size by Country
    • 9.4.1 Latin America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    • 9.4.2 Latin America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 10.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Takeda
    • 11.1.1 Takeda Company Details
    • 11.1.2 Takeda Business Overview
    • 11.1.3 Takeda Lysosomal Storage Disease Treatment Introduction
    • 11.1.4 Takeda Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.1.5 Takeda Recent Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Lysosomal Storage Disease Treatment Introduction
    • 11.2.4 Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.2.5 Pfizer Recent Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Company Details
    • 11.3.2 Sanofi Business Overview
    • 11.3.3 Sanofi Lysosomal Storage Disease Treatment Introduction
    • 11.3.4 Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.3.5 Sanofi Recent Developments
  • 11.4 BioMarin
    • 11.4.1 BioMarin Company Details
    • 11.4.2 BioMarin Business Overview
    • 11.4.3 BioMarin Lysosomal Storage Disease Treatment Introduction
    • 11.4.4 BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.4.5 BioMarin Recent Developments
  • 11.5 Merck
    • 11.5.1 Merck Company Details
    • 11.5.2 Merck Business Overview
    • 11.5.3 Merck Lysosomal Storage Disease Treatment Introduction
    • 11.5.4 Merck Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.5.5 Merck Recent Developments
  • 11.6 Actelion Pharmaceuticals
    • 11.6.1 Actelion Pharmaceuticals Company Details
    • 11.6.2 Actelion Pharmaceuticals Business Overview
    • 11.6.3 Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Introduction
    • 11.6.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.6.5 Actelion Pharmaceuticals Recent Developments
  • 11.7 Eli Lilly
    • 11.7.1 Eli Lilly Company Details
    • 11.7.2 Eli Lilly Business Overview
    • 11.7.3 Eli Lilly Lysosomal Storage Disease Treatment Introduction
    • 11.7.4 Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.7.5 Eli Lilly Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
Show more

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Enzyme Replacement Therapy
    • 1.2.3 Stem Cell Transplantation
    • 1.2.4 Substrate Reduction Therapy
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Stem Transplant Centers
    • 1.3.5 Research Organizations
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Lysosomal Storage Disease Treatment Market Perspective (2017-2028)
  • 2.2 Lysosomal Storage Disease Treatment Growth Trends by Region
    • 2.2.1 Lysosomal Storage Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Lysosomal Storage Disease Treatment Historic Market Size by Region (2017-2022)
    • 2.2.3 Lysosomal Storage Disease Treatment Forecasted Market Size by Region (2023-2028)
  • 2.3 Lysosomal Storage Disease Treatment Market Dynamics
    • 2.3.1 Lysosomal Storage Disease Treatment Industry Trends
    • 2.3.2 Lysosomal Storage Disease Treatment Market Drivers
    • 2.3.3 Lysosomal Storage Disease Treatment Market Challenges
    • 2.3.4 Lysosomal Storage Disease Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue
    • 3.1.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue (2017-2022)
    • 3.1.2 Global Lysosomal Storage Disease Treatment Revenue Market Share by Players (2017-2022)
  • 3.2 Global Lysosomal Storage Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Lysosomal Storage Disease Treatment Revenue
  • 3.4 Global Lysosomal Storage Disease Treatment Market Concentration Ratio
    • 3.4.1 Global Lysosomal Storage Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Disease Treatment Revenue in 2021
  • 3.5 Lysosomal Storage Disease Treatment Key Players Head office and Area Served
  • 3.6 Key Players Lysosomal Storage Disease Treatment Product Solution and Service
  • 3.7 Date of Enter into Lysosomal Storage Disease Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Lysosomal Storage Disease Treatment Breakdown Data by Type

  • 4.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Type (2017-2022)
  • 4.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Type (2023-2028)

5 Lysosomal Storage Disease Treatment Breakdown Data by Application

  • 5.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Application (2017-2022)
  • 5.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 6.2 North America Lysosomal Storage Disease Treatment Market Size by Type
    • 6.2.1 North America Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 6.2.2 North America Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 6.2.3 North America Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 6.3 North America Lysosomal Storage Disease Treatment Market Size by Application
    • 6.3.1 North America Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 6.3.2 North America Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 6.3.3 North America Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 6.4 North America Lysosomal Storage Disease Treatment Market Size by Country
    • 6.4.1 North America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    • 6.4.2 North America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 7.2 Europe Lysosomal Storage Disease Treatment Market Size by Type
    • 7.2.1 Europe Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 7.2.2 Europe Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 7.2.3 Europe Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 7.3 Europe Lysosomal Storage Disease Treatment Market Size by Application
    • 7.3.1 Europe Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 7.3.2 Europe Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 7.3.3 Europe Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 7.4 Europe Lysosomal Storage Disease Treatment Market Size by Country
    • 7.4.1 Europe Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    • 7.4.2 Europe Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 8.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 9.2 Latin America Lysosomal Storage Disease Treatment Market Size by Type
    • 9.2.1 Latin America Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 9.2.2 Latin America Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 9.2.3 Latin America Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 9.3 Latin America Lysosomal Storage Disease Treatment Market Size by Application
    • 9.3.1 Latin America Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 9.3.2 Latin America Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 9.3.3 Latin America Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 9.4 Latin America Lysosomal Storage Disease Treatment Market Size by Country
    • 9.4.1 Latin America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    • 9.4.2 Latin America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size (2017-2028)
  • 10.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Takeda
    • 11.1.1 Takeda Company Details
    • 11.1.2 Takeda Business Overview
    • 11.1.3 Takeda Lysosomal Storage Disease Treatment Introduction
    • 11.1.4 Takeda Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.1.5 Takeda Recent Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Lysosomal Storage Disease Treatment Introduction
    • 11.2.4 Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.2.5 Pfizer Recent Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Company Details
    • 11.3.2 Sanofi Business Overview
    • 11.3.3 Sanofi Lysosomal Storage Disease Treatment Introduction
    • 11.3.4 Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.3.5 Sanofi Recent Developments
  • 11.4 BioMarin
    • 11.4.1 BioMarin Company Details
    • 11.4.2 BioMarin Business Overview
    • 11.4.3 BioMarin Lysosomal Storage Disease Treatment Introduction
    • 11.4.4 BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.4.5 BioMarin Recent Developments
  • 11.5 Merck
    • 11.5.1 Merck Company Details
    • 11.5.2 Merck Business Overview
    • 11.5.3 Merck Lysosomal Storage Disease Treatment Introduction
    • 11.5.4 Merck Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.5.5 Merck Recent Developments
  • 11.6 Actelion Pharmaceuticals
    • 11.6.1 Actelion Pharmaceuticals Company Details
    • 11.6.2 Actelion Pharmaceuticals Business Overview
    • 11.6.3 Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Introduction
    • 11.6.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.6.5 Actelion Pharmaceuticals Recent Developments
  • 11.7 Eli Lilly
    • 11.7.1 Eli Lilly Company Details
    • 11.7.2 Eli Lilly Business Overview
    • 11.7.3 Eli Lilly Lysosomal Storage Disease Treatment Introduction
    • 11.7.4 Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2017-2022)
    • 11.7.5 Eli Lilly Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
Show more
  • Table 1. Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Enzyme Replacement Therapy
  • Table 3. Key Players of Stem Cell Transplantation
  • Table 4. Key Players of Substrate Reduction Therapy
  • Table 5. Key Players of Others
  • Table 6. Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Lysosomal Storage Disease Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Lysosomal Storage Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Lysosomal Storage Disease Treatment Market Share by Region (2017-2022)
  • Table 10. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Lysosomal Storage Disease Treatment Market Share by Region (2023-2028)
  • Table 12. Lysosomal Storage Disease Treatment Market Trends
  • Table 13. Lysosomal Storage Disease Treatment Market Drivers
  • Table 14. Lysosomal Storage Disease Treatment Market Challenges
  • Table 15. Lysosomal Storage Disease Treatment Market Restraints
  • Table 16. Global Lysosomal Storage Disease Treatment Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Lysosomal Storage Disease Treatment Revenue Share by Players (2017-2022)
  • Table 18. Global Top Lysosomal Storage Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Disease Treatment as of 2021)
  • Table 19. Ranking of Global Top Lysosomal Storage Disease Treatment Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Lysosomal Storage Disease Treatment Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Lysosomal Storage Disease Treatment Product Solution and Service
  • Table 23. Date of Enter into Lysosomal Storage Disease Treatment Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Lysosomal Storage Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2017-2022)
  • Table 27. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2023-2028)
  • Table 29. Global Lysosomal Storage Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Lysosomal Storage Disease Treatment Revenue Share by Application (2017-2022)
  • Table 31. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Lysosomal Storage Disease Treatment Revenue Share by Application (2023-2028)
  • Table 33. North America Lysosomal Storage Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Lysosomal Storage Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Lysosomal Storage Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Lysosomal Storage Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Lysosomal Storage Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Lysosomal Storage Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Lysosomal Storage Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Lysosomal Storage Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Lysosomal Storage Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Lysosomal Storage Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Lysosomal Storage Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Lysosomal Storage Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Lysosomal Storage Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Lysosomal Storage Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Lysosomal Storage Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Lysosomal Storage Disease Treatment Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Lysosomal Storage Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Lysosomal Storage Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Lysosomal Storage Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Lysosomal Storage Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Lysosomal Storage Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Lysosomal Storage Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Lysosomal Storage Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Lysosomal Storage Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Lysosomal Storage Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Lysosomal Storage Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Lysosomal Storage Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Lysosomal Storage Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Takeda Company Details
  • Table 64. Takeda Business Overview
  • Table 65. Takeda Lysosomal Storage Disease Treatment Product
  • Table 66. Takeda Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
  • Table 67. Takeda Recent Developments
  • Table 68. Pfizer Company Details
  • Table 69. Pfizer Business Overview
  • Table 70. Pfizer Lysosomal Storage Disease Treatment Product
  • Table 71. Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
  • Table 72. Pfizer Recent Developments
  • Table 73. Sanofi Company Details
  • Table 74. Sanofi Business Overview
  • Table 75. Sanofi Lysosomal Storage Disease Treatment Product
  • Table 76. Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
  • Table 77. Sanofi Recent Developments
  • Table 78. BioMarin Company Details
  • Table 79. BioMarin Business Overview
  • Table 80. BioMarin Lysosomal Storage Disease Treatment Product
  • Table 81. BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
  • Table 82. BioMarin Recent Developments
  • Table 83. Merck Company Details
  • Table 84. Merck Business Overview
  • Table 85. Merck Lysosomal Storage Disease Treatment Product
  • Table 86. Merck Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
  • Table 87. Merck Recent Developments
  • Table 88. Actelion Pharmaceuticals Company Details
  • Table 89. Actelion Pharmaceuticals Business Overview
  • Table 90. Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Product
  • Table 91. Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
  • Table 92. Actelion Pharmaceuticals Recent Developments
  • Table 93. Eli Lilly Company Details
  • Table 94. Eli Lilly Business Overview
  • Table 95. Eli Lilly Lysosomal Storage Disease Treatment Product
  • Table 96. Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2017-2022) & (US$ Million)
  • Table 97. Eli Lilly Recent Developments
  • Table 98. Research Programs/Design for This Report
  • Table 99. Key Data Information from Secondary Sources
  • Table 100. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Lysosomal Storage Disease Treatment Market Share by Type: 2021 VS 2028
  • Figure 2. Enzyme Replacement Therapy Features
  • Figure 3. Stem Cell Transplantation Features
  • Figure 4. Substrate Reduction Therapy Features
  • Figure 5. Others Features
  • Figure 6. Global Lysosomal Storage Disease Treatment Market Share by Application: 2021 VS 2028
  • Figure 7. Hospitals Case Studies
  • Figure 8. Clinics Case Studies
  • Figure 9. Stem Transplant Centers Case Studies
  • Figure 10. Research Organizations Case Studies
  • Figure 11. Others Case Studies
  • Figure 12. Lysosomal Storage Disease Treatment Report Years Considered
  • Figure 13. Global Lysosomal Storage Disease Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 14. Global Lysosomal Storage Disease Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 15. Global Lysosomal Storage Disease Treatment Market Share by Region: 2021 VS 2028
  • Figure 16. Global Lysosomal Storage Disease Treatment Market Share by Players in 2021
  • Figure 17. Global Top Lysosomal Storage Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Disease Treatment as of 2021)
  • Figure 18. The Top 10 and 5 Players Market Share by Lysosomal Storage Disease Treatment Revenue in 2021
  • Figure 19. North America Lysosomal Storage Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 20. North America Lysosomal Storage Disease Treatment Market Size Market Share by Type (2017-2028)
  • Figure 21. North America Lysosomal Storage Disease Treatment Market Size Market Share by Application (2017-2028)
  • Figure 22. North America Lysosomal Storage Disease Treatment Market Size Share by Country (2017-2028)
  • Figure 23. United States Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Canada Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Europe Lysosomal Storage Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 26. Europe Lysosomal Storage Disease Treatment Market Size Market Share by Type (2017-2028)
  • Figure 27. Europe Lysosomal Storage Disease Treatment Market Size Market Share by Application (2017-2028)
  • Figure 28. Europe Lysosomal Storage Disease Treatment Market Size Share by Country (2017-2028)
  • Figure 29. Germany Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. France Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. U.K. Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Italy Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Russia Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Nordic Countries Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Asia-Pacific Lysosomal Storage Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 36. Asia Pacific Lysosomal Storage Disease Treatment Market Size Market Share by Type (2017-2028)
  • Figure 37. Asia Pacific Lysosomal Storage Disease Treatment Market Size Market Share by Application (2017-2028)
  • Figure 38. Asia Pacific Lysosomal Storage Disease Treatment Market Size Share by Region (2017-2028)
  • Figure 39. China Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Japan Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. South Korea Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Southeast Asia Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. India Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Australia Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 45. Latin America Lysosomal Storage Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 46. Latin America Lysosomal Storage Disease Treatment Market Size Market Share by Type (2017-2028)
  • Figure 47. Latin America Lysosomal Storage Disease Treatment Market Size Market Share by Application (2017-2028)
  • Figure 48. Latin America Lysosomal Storage Disease Treatment Market Size Share by Country (2017-2028)
  • Figure 49. Mexico Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Brazil Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 51. Middle East & Africa Lysosomal Storage Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 52. Middle East and Africa Lysosomal Storage Disease Treatment Market Size Market Share by Type (2017-2028)
  • Figure 53. Middle East and Africa Lysosomal Storage Disease Treatment Market Size Market Share by Application (2017-2028)
  • Figure 54. Middle East and Africa Lysosomal Storage Disease Treatment Market Size Share by Country (2017-2028)
  • Figure 55. Turkey Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Saudi Arabia Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. UAE Lysosomal Storage Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 58. Takeda Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
  • Figure 59. Pfizer Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
  • Figure 60. Sanofi Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
  • Figure 61. BioMarin Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
  • Figure 62. Merck Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
  • Figure 63. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
  • Figure 64. Eli Lilly Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2017-2022)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!